Patrick F. Kelly,Alan Collis,Jeff Davis,Duncan Walker,Susan Ashwell,Blythe Thomson
申请号:
US16693585
公开号:
US20200108060A1
申请日:
2019.11.25
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Methods of treating patients diagnosed with cancer harboring an IDH-1 mutation are provided, including the therapeutic administration of a certain inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA).